We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Personal Activity Intelligence Versus 10,000 Steps Daily on Cardiorespiratory Fitness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03336047
Recruitment Status : Completed
First Posted : November 8, 2017
Last Update Posted : August 4, 2020
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:

A high physical fitness can prevent cardiovascular disease. Which form of exercise training is efficient at improving fitness is well known. The challenge is to get people to do it. Personal activity intelligence (PAI) is an algorithm developed for this challenge. It gives a score that tells the users whether they are active enough to achieve the maximum health benefit of exercise based on their heart rate. It has been shown that people who obtain 100 PAI a week have less cardiovascular disease, but intervention studies showing that PAI can improve physical fitness are so far lacking.

Step counters have received a lot of attention and 10 000 steps a day is a common recommendation, but little is known about the physiological adaptations to this intervention.

This study will compare the effect of physical activity with a value of 100 PAI points a week with 10 000 steps a day in healthy, but overweight (body mass index > 25) participants between 30 and 50 years of age.


Condition or disease Intervention/treatment Phase
Obesity Physical Activity Behavioral: personal activity intelligence Behavioral: 10,000 steps daily Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 21 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Effect of Personal Activity Intelligence Versus 10,000 Steps Daily on Cardiorespiratory Fitness in Overweight and Obese
Actual Study Start Date : November 15, 2017
Actual Primary Completion Date : February 15, 2018
Actual Study Completion Date : February 15, 2018

Arm Intervention/treatment
Active Comparator: 10,000 steps daily
Subjects will be encouraged to obtain 10 000 steps a day, monitored by a step counter (fit bit zip)
Behavioral: 10,000 steps daily
Participants randomized to the 10,000 step intervention will receive a fit bit zip step counter and asked to obtain 10.000 steps per day. Participants will be encouraged to obtain 10.000 steps per day by telephone messages (sms).

Experimental: using personal activity intelligence
Subjects will be encouraged to obtain 100 PAI points per week, monitored by Mio Slice and the Mio Pai 2.0 smart phone application
Behavioral: personal activity intelligence

Participants randomized to the PAI intervention will receive a Mio Slice fitness bracelet and asked to install the Mio Pai 2.0 app on their smart phone. This tracks their fitness score based on the PAI algorithm where the goal is to maintain 100 PAI points a week. PAI is earned incrementally based on time spent in three different heart rate zones, low, medium and high intensity. PAI is recorded every day and added to the weekly total and the PAI earned on the same day the previous week is deleted (on Tuesday, the PAI earned the previous Tuesday will disappear).

Participants will be encouraged to maintain 100 PAI during the 8 weeks intervention by telephone messages (sms).

Other Name: PAI




Primary Outcome Measures :
  1. Maximal oxygen uptake [ Time Frame: After the intervention period (8 weeks) ]
    The highest amount of oxygen the body can take up, achieved at maximal exercise at the end of an incremental treadmill test measured through ergospirometry. The difference between the two groups post-intervention will be used, while controlling for a pre-intervention value.


Secondary Outcome Measures :
  1. Body composition [ Time Frame: After intervention period (8 weeks) ]

    Body mass, fat mass and lean mass will be measured using a bio impedance analysis which weighs the participants and uses bio impedance to also assess fat mass and lean mass.

    The difference between the two groups post-intervention will be used, while controlling for a pre-intervention value.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   30 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Body mass index (BMI) > 25
  • Low physical activity (less than 50 PAI points calculated from a questionnaire)

Exclusion Criteria:

  • Cancer diagnosis
  • Cardiac arrhythmia
  • Angina
  • Previous myocardial infarction
  • lung disease
  • heart disease
  • uncontrolled hypertension
  • kidney disease
  • orthopedic or neurological limitations
  • planned surgery during the intervention
  • participation in other research studies conflicting with the current study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03336047


Locations
Layout table for location information
Norway
St. Olavs Hospital
Trondheim, Sør Trøndelag, Norway, 7030
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Layout table for investigator information
Principal Investigator: Fredrik Hjulstad Bækkerud Norwegian University of Science and Technology
Study Director: Ulrik Wisløff, phd prof Norwegian University of Science and Technology
Layout table for additonal information
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT03336047    
Other Study ID Numbers: 2017/1211
First Posted: November 8, 2017    Key Record Dates
Last Update Posted: August 4, 2020
Last Verified: August 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Norwegian University of Science and Technology:
Exercise
Actigraphy
Prevention and Control
Cardiorespiratory Fitness